NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation (NMTC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nmtc · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for NeuroOne Medical Technologies Corporation (NMTC) measures how much investors pay for each dollar of the company's trailing earnings. NMTC's current PE ratio of N/A is calculated by dividing its stock price of $3.48 by its TTM earnings per share of -$0.79.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2010 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
NeuroOne Medical Technologies CorporationYou NMTC | $30M | N/A | — | -$0.79 |
 Alterity Therapeutics Limited ATHE | $39M | N/A | — | -$1.14 |
 Baird Medical Investment Holdings Limited BDMD | $52M | N/A | — | -$0.98 |
 Cytosorbents Corporation CTSO | $27M | N/A | — | -$0.13 |
 electroCore, Inc. ECOR | $80M | N/A | — | -$1.65 |
 Hyperion DeFi, Inc. HYPD | $14M | N/A | — | -$9.06 |
 Myomo, Inc. MYO | $54M | N/A | — | -$0.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-0.54 | — | |
2024-09-30 FY2024 | — | $-2.76 | — | |
2023-09-30 FY2023 | — | $-3.93 | — | |
2022-09-30 FY2022 | — | $-3.75 | — | |
2021-09-30 FY2021 | — | $-5.58 | — | |
2020-09-30 FY2020 | — | $-15.11 | — | |
2019-09-30 FY2019 | — | $-10.29 | — | |
2018-09-30 FY2018 | — | $-14.59 | — | |
2017-12-31 FY2017 | — | $-13.77 | — | |
2016-12-31 FY2016 | — | $-0.17 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for NeuroOne Medical Technologies Corporation (NMTC) measures how much investors pay for each dollar of the company's trailing earnings. NMTC's current PE ratio of N/A is calculated by dividing its stock price of $3.48 by its TTM earnings per share of -$0.79.
Frequently asked questions
NMTC pe ratio · 6 questionsNMTC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.48 and TTM EPS of -$0.79. Data sourced from Financial Modeling Prep via NMTC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NeuroOne Medical Technologies Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09